Full text
| |
| Author(s): |
Marcio Hideki Matsubara
Total Authors: 1
|
| Document type: | Master's Dissertation |
| Press: | São Paulo. |
| Institution: | Universidade de São Paulo (USP). Instituto de Ciências Biomédicas (ICB/SDI) |
| Defense date: | 2009-05-06 |
| Examining board members: |
Catarina de Fatima Pereira Teixeira;
Inácio de Loiola Meirelles Junqueira de Azevedo;
Sandra Helena Poliselli Farsky
|
| Advisor: | Catarina de Fatima Pereira Teixeira |
| Abstract | |
Crotalus durissus terrificus snake venom (CdtV) and their components induces systemic effects, which interfere with blood vessel system. Endothelial cells (EC) are central elements for haemostasis, regulating blood vessel-wall permeability, blood fluidity and adhesion properties of circulating leukocytes. However, there is no available data on the effects of this venom and its components on endothelial cells. In this study, the effects of CdtV, crotoxin (CTX) which is formed by two distinct subunits named crotapotin (CA) and phospholipase A2 (CB), on endothelial cells in vitro were investigated, analyzing EC viability and proliferation, EC monolayers integrity, release of both nitric oxide and prostacyclin (PGI2). CdtV, at the highest concentration, time-dependently decreased the viability of EC and the integrity of cell monolayers. The CB subunit, but not CTX nor CA, reproduced the effects caused by crude venom. In contrast, neither EC proliferation nor release of oxide nitric were affected by non-cytotoxic concentrations of CdtV or isolated toxins. However, at the same experimental condition, both CdtV and CB increased the prostacyclin release by endothelium through activation of COX-1 and -2 enzyme systems. Moreover, these toxins upregulated protein expression of COX-2 isoform, but did not alter constitutive expression of COX-1. On the other hand, neither CTX nor CA affected basal production of PGI2. Inhibition of cytosolic PLA2 (cPLA2) by AACOCF3 significantly reduced PGI2 increments caused by both CdtV and CB implying that cPLA2 cooperates for the synthesis of PGI2 induced by them. Inhibition of the catalytic activity of CB abrogated its ability to induce the release of PGI2, thus suggesting the importance of the phospholipase A2 enzyme activity for this effect. These findings provide evidence that CdtV and CB can directly activate EC and up-regulate cyclooxygenase pathways for production of prostacyclin, an important mediator of vasodilation and inflammation. Moreover, CB through its catalytic activity may significantly contribute for the stimulatory effect of CdtV in EC. Therefore, these findings indicate novel regulatory mechanisms for both CdtV and venom secretory PLA2 in endothelial cells. (AU) | |